Kenji Nakano

18PUBLICATIONS
21CO-AUTHORS
Molecular targetsGene and molecular therapyRadiation therapyTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Feb 27, 2026
The Development of Novel Treatment Strategies for Rhabdomyosarcoma.

Kenji Nakano

|Dec 15, 2025
The first case of GOLGA5-RET fusion-positive malignant spindle cell sarcoma of the head and neck responsive to selpercatinib.

Takehiro Nakao, Naoki Fukuda, Xiaofei Wang

|Jan 31, 2024
Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.

Naoki Fukuda, Kazuhisa Toda, Hirotaka Suto

|Dec 09, 2023
The Future of HER2-Targeted Treatment for Osteosarcoma: Lessons from the Negative Trastuzumab Deruxtecan Results.

Kenji Nakano

|Jul 03, 2023
Inflammatory myofibroblastic tumors: recent progress and future of targeted therapy.

Kenji Nakano

|May 31, 2022
Platinum-doublet chemotherapy for advanced gastroenteropancreatic neuroendocrine carcinoma: a systematic review and meta-analysis.

Akihiro Ohmoto, Yu Fujiwara, Nobuyuki Horita

Pageof 3

Frequent Collaborators

5 joint publications

Naoki Fukuda

3 joint publications

Yasuyoshi Sato

3 joint publications

Shunji Takahashi

3 joint publications

Junichi Tomomatsu